Evidence map›Paper›PMID 26881043›Full record

ReviewOxidative medicine and cellular longevity2016

A Potential Alternative against Neurodegenerative Diseases: Phytodrugs.

Jesús Pérez-Hernández, Víctor Javier Zaldívar-Machorro, David Villanueva-Porras, Elisa Vega-Ávila, Anahí Chavarría

Open access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
23.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. International journal of molecular sciences · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Neuroprotective Potential of Tamarillo (Frontiers in nutrition · 2021
    Article
  16. Article
  17. Neuroprotective Effects of 7-Geranyloxycinnamic Acid fromMolecules (Basel, Switzerland) · 2020
    Article
  18. Genome-Protecting Compounds as Potential Geroprotectors.International journal of molecular sciences · 2020
    Review
  19. Article
  20. Frontiers in cellular neuroscience · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jesús Pérez-HernándezDepartamento de Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México, 06726 México, DF, Mexico; Posgrado en Biología Experimental, Universidad Autónoma Metropolitana-Iztapalapa, 09340 México, DF, Mexico.
Víctor Javier Zaldívar-MachorroDepartamento de Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México, 06726 México, DF, Mexico; Programa de Becas Posdoctorales, Universidad Nacional Autónoma de México, 04510 México, DF, Mexico.
David Villanueva-PorrasDepartamento de Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México, 06726 México, DF, Mexico; Posgrado en Ciencias Biomédicas, Universidad Nacional Autónoma de México, 04510 México, DF, Mexico.
Elisa Vega-ÁvilaDivisión de Ciencias Biológicas y de la Salud, Universidad Autónoma Metropolitana, 09340 México, DF, Mexico.
Anahí ChavarríaDepartamento de Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México, 06726 México, DF, Mexico.
Universidad Nacional Autónoma de México · MXUniversidad Autónoma Metropolitana · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurodegenerative diseases (ND) primarily affect the neurons in the human brain secondary to oxidative stress and neuroinflammation. ND are more common and have a disproportionate impact on countries with longer life expectancies and represent the fourth highest source of overall disease burden in the high-income countries. A large majority of the medicinal plant compounds, such as polyphenols, alkaloids, and terpenes, have therapeutic properties. Polyphenols are the most common active compounds in herbs and vegetables consumed by man. The biological bioactivity of polyphenols against neurodegeneration is mainly due to its antioxidant, anti-inflammatory, and antiamyloidogenic effects. Multiple scientific studies support the use of herbal medicine in the treatment of ND; however, relevant aspects are still pending to explore such as metabolic analysis, pharmacokinetics, and brain bioavailability.

Indexed as

PhytotherapyAlkaloidsAnimalsAnti-Inflammatory AgentsAntioxidantsBiological AvailabilityBrain IschemiaCell MembraneCentral Nervous SystemDNA DamageHumansInflammationMaleMiceMitochondriaNeurodegenerative DiseasesAlkaloidsAnti-Inflammatory AgentsAntioxidantsPhytochemicalsPlant ExtractsPolyphenolsTerpenes

Identifiers

PMID26881043
PMCPMC4736801
OpenAlexW2230921923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.